Variant report

Variant	nsv550263
Chromosome Location	chr10:27633772-27694764
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:901)
CpG islands
(count:244)
Chromatin interactive
region (count:16)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:901 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr10:27672857-27673169	HepG2	liver:	n/a	n/a
2	ARID3A	chr10:27649547-27649808	K562	blood:	n/a	n/a
3	ATF1	chr10:27649531-27649804	K562	blood:	n/a	n/a
4	BATF	chr10:27633841-27634192	GM12878	blood:	n/a	n/a
5	BATF	chr10:27643692-27643988	GM12878	blood:	n/a	n/a
6	BATF	chr10:27649564-27649764	GM12878	blood:	n/a	n/a
7	BCL11A	chr10:27643724-27643987	GM12878	blood:	n/a	n/a
8	BCL11A	chr10:27643658-27644039	GM12878	blood:	n/a	n/a
9	BCL3	chr10:27672617-27673252	A549	lung:	n/a	n/a
10	BCLAF1	chr10:27643572-27643923	GM12878	blood:	n/a	n/a
11	BHLHE40	chr10:27646116-27646388	K562	blood:	n/a	chr10:27646219-27646232 chr10:27646221-27646230 chr10:27646222-27646231 chr10:27646221-27646230
12	BHLHE40	chr10:27649567-27649799	K562	blood:	n/a	n/a
13	BHLHE40	chr10:27672558-27673044	HepG2	liver:	n/a	n/a
14	BHLHE40	chr10:27649517-27649830	GM12878	blood:	n/a	n/a
15	BHLHE40	chr10:27633890-27634818	GM12878	blood:	n/a	n/a
16	BRCA1	chr10:27672817-27673127	Hela-S3	cervix:	n/a	n/a
17	CBX3	chr10:27681617-27681837	K562	blood:	n/a	n/a
18	CBX3	chr10:27681602-27681815	K562	blood:	n/a	n/a
19	CCNT2	chr10:27639061-27639239	K562	blood:	n/a	n/a
20	CCNT2	chr10:27649596-27649806	K562	blood:	n/a	n/a
21	CEBPB	chr10:27677736-27678037	IMR90	lung:	n/a	chr10:27677849-27677860
22	CEBPB	chr10:27649533-27649818	A549	lung:	n/a	chr10:27649675-27649686
23	CEBPB	chr10:27672728-27673265	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr10:27649503-27649883	K562	blood:	n/a	chr10:27649675-27649686
25	CEBPB	chr10:27672658-27673316	A549	lung:	n/a	n/a
26	CEBPB	chr10:27680208-27680388	Hela-S3	cervix:	n/a	n/a
27	CEBPB	chr10:27634350-27634708	IMR90	lung:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
28	CEBPB	chr10:27662837-27663055	K562	blood:	n/a	chr10:27662910-27662921
29	CEBPB	chr10:27662820-27663067	HepG2	liver:	n/a	chr10:27662910-27662921
30	CEBPB	chr10:27672755-27673183	A549	lung:	n/a	n/a
31	CEBPB	chr10:27659541-27659772	HepG2	liver:	n/a	chr10:27659628-27659639 chr10:27659627-27659638 chr10:27659627-27659640
32	CEBPB	chr10:27669848-27670363	HepG2	liver:	n/a	chr10:27669887-27669899
33	CEBPB	chr10:27649513-27649869	IMR90	lung:	n/a	chr10:27649675-27649686
34	CEBPB	chr10:27634311-27634682	A549	lung:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
35	CEBPB	chr10:27649575-27649846	HepG2	liver:	n/a	chr10:27649675-27649686
36	CEBPB	chr10:27653947-27654086	K562	blood:	n/a	n/a
37	CEBPB	chr10:27672803-27673162	MCF-7	breast:	n/a	n/a
38	CEBPB	chr10:27677693-27677915	MCF-7	breast:	n/a	chr10:27677849-27677860
39	CEBPB	chr10:27677675-27678050	Hela-S3	cervix:	n/a	chr10:27677849-27677860
40	CEBPB	chr10:27655050-27655300	K562	blood:	n/a	chr10:27655162-27655173 chr10:27655161-27655172 chr10:27655161-27655174
41	CEBPB	chr10:27672818-27673157	HepG2	liver:	n/a	n/a
42	CEBPB	chr10:27677739-27678016	HepG2	liver:	n/a	chr10:27677849-27677860
43	CEBPB	chr10:27684721-27685002	Hela-S3	cervix:	n/a	chr10:27684883-27684896
44	CEBPB	chr10:27655035-27655235	HepG2	liver:	n/a	chr10:27655162-27655173 chr10:27655161-27655172 chr10:27655161-27655174
45	CEBPB	chr10:27634266-27634780	HepG2	liver:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
46	CEBPB	chr10:27679600-27679898	Hela-S3	cervix:	n/a	n/a
47	CEBPB	chr10:27672754-27673203	A549	lung:	n/a	n/a
48	CEBPB	chr10:27634283-27634772	Hela-S3	cervix:	n/a	chr10:27634411-27634420 chr10:27634411-27634422
49	CHD1	chr10:27643797-27643865	GM12878	blood:	n/a	n/a
50	CHD2	chr10:27672857-27673148	Hela-S3	cervix:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:27633745-27633795	HUVEC	blood vessel:	n/a
2	chr10:27639156-27639206	HCF	heart:	n/a
3	chr10:27639136-27639186	GM12892	blood:	n/a
4	chr10:27633745-27633795	HCT-116	colon:	n/a
5	chr10:27639136-27639186	SKMC	muscle:	n/a
6	chr10:27639136-27639186	Hela-S3	cervix:	n/a
7	chr10:27634719-27634769	T-47D	breast:	n/a
8	chr10:27639156-27639206	SK-N-SH_RA	brain:	n/a
9	chr10:27633745-27633795	SK-N-SH_RA	brain:	n/a
10	chr10:27639136-27639186	MCF-7	breast:	n/a
11	chr10:27639136-27639186	T-47D	breast:	n/a
12	chr10:27639156-27639206	ProgFib	skin:	n/a
13	chr10:27639136-27639186	Hepatocyte	liver:	n/a
14	chr10:27633745-27633795	SAEC	small airway:	n/a
15	chr10:27633745-27633795	HCPEpiC	choroid plexus:	n/a
16	chr10:27639136-27639186	SAEC	small airway:	n/a
17	chr10:27639156-27639206	SKMC	muscle:	n/a
18	chr10:27639136-27639186	PrEC	prostate:	n/a
19	chr10:27639136-27639186	PANC-1	pancreas:	n/a
20	chr10:27634719-27634769	HL-60	blood:	n/a
21	chr10:27633745-27633795	GM06990	blood:	n/a
22	chr10:27639136-27639186	ProgFib	skin:	n/a
23	chr10:27639156-27639206	HMEC	breast:	n/a
24	chr10:27634719-27634769	PrEC	prostate:	n/a
25	chr10:27633745-27633795	PrEC	prostate:	n/a
26	chr10:27633745-27633795	BE2_C	brain:	n/a
27	chr10:27633745-27633795	AG09309	skin:	n/a
28	chr10:27639136-27639186	HRPEpiC	eye:	n/a
29	chr10:27639136-27639186	AG09319	gingival:	n/a
30	chr10:27639136-27639186	HCF	heart:	n/a
31	chr10:27634719-27634769	SAEC	small airway:	n/a
32	chr10:27634719-27634769	NHBE	bronchial:	n/a
33	chr10:27633745-27633795	GM12878	blood:	n/a
34	chr10:27634719-27634769	HEEpiC	esophagus:	n/a
35	chr10:27633745-27633795	Hela-S3	cervix:	n/a
36	chr10:27639136-27639186	ovcar-3	ovarian:	n/a
37	chr10:27639136-27639186	HUVEC	blood vessel:	n/a
38	chr10:27639136-27639186	LNCaP	prostate:	n/a
39	chr10:27634719-27634769	Hela-S3	cervix:	n/a
40	chr10:27639136-27639186	ECC-1	luminal epithelium:	n/a
41	chr10:27639136-27639186	HAEpiC	amniotic membrane:	n/a
42	chr10:27634719-27634769	HNPCEpiC	eye:	n/a
43	chr10:27639156-27639206	H1-hESC	embryonic stem cell:	embryo
44	chr10:27634719-27634769	HCT-116	colon:	n/a
45	chr10:27639156-27639206	AG09309	skin:	n/a
46	chr10:27639136-27639186	U87	brain:	n/a
47	chr10:27634719-27634769	HRCEpiC	kidney:	n/a
48	chr10:27639156-27639206	HRPEpiC	eye:	n/a
49	chr10:27639156-27639206	NHDF-neo	bronchial:	n/a
50	chr10:27634719-27634769	AG04450	lung:	fetal

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:27681780..27685010-chr10:27685683..27688279,3	K562	blood:
2	chr10:27681780..27685010-chr10:27685683..27688279,3	K562	blood:
3	chr10:27640371..27642415-chr10:27644846..27646556,2	K562	blood:
4	chr10:27669052..27671269-chr10:27683257..27685068,2	K562	blood:
5	chr10:27659927..27662822-chr10:27662832..27664720,3	K562	blood:
6	chr10:27527860..27530153-chr10:27647076..27648802,2	MCF-7	breast:
7	chr10:27441984..27445191-chr10:27642152..27645235,3	MCF-7	breast:
8	chr10:27530526..27532390-chr10:27644695..27646372,2	MCF-7	breast:
9	chr10:27659927..27662822-chr10:27662832..27664720,3	K562	blood:
10	chr10:27640371..27642415-chr10:27644846..27646556,2	K562	blood:
11	chr10:27529763..27532096-chr10:27643724..27645777,2	MCF-7	breast:
12	chr10:27669052..27671269-chr10:27683257..27685068,2	K562	blood:
13	chr10:27684512..27686768-chr10:27700849..27702736,2	K562	blood:
14	chr10:27531028..27532588-chr10:27647976..27649755,2	K562	blood:
15	chr10:27694442..27697083-chr10:27703247..27705702,3	K562	blood:
16	chr10:27659175..27661663-chr10:27792060..27794224,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MASTL-2	chr10:27633668-27633846	ENSG00000260151.1
2	lnc-PTCHD3-1	chr10:27667067-27667291	NONHSAT011904
3	lnc-PTCHD3-2	chr10:27634694-27635239	l_277_chr10:27627368-27636725_testes
4	lnc-PTCHD3-2	chr10:27636298-27636725	l_277_chr10:27627368-27636725_testes

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	PTCHD3	hsa-miR-128-3p	chr10:27687123-27687143

Variant related genes	Relation type
TRIAP1P1	TF binding region
FAM210CP	TF binding region
ENSG00000215409	TF binding region
TRIAP1P1	CpG island
FAM210CP	CpG island
ENSG00000215409	CpG island
ENSG00000120539	chromatin interactions
ENSG00000136758	chromatin interactions
ENSG00000182077	chromatin interactions
ENSG00000107897	chromatin interactions
ENSG00000099246	chromatin interactions
ENSG00000262412	chromatin interactions

Extended variants
information (count: 1738 )
Associated
traits (count: 46 )

Variant overlapped rSNPs/rCNVs (count:1738 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10490914	chr10:27633772-27633773	Enhancers	TF binding region CpG island lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs559202784	chr10:27633807-27633808	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs569463838	chr10:27633831-27633832	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs79636096	chr10:27633840-27633841	Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs147547751	chr10:27633862-27633863	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs376225768	chr10:27633866-27633867	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs71487882	chr10:27633877-27633878	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs79843427	chr10:27633892-27633893	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs185783601	chr10:27633906-27633907	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs540635739	chr10:27633911-27633912	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs192298379	chr10:27633914-27633915	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs75487815	chr10:27633938-27633939	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs545653997	chr10:27633945-27633946	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs138676506	chr10:27633967-27633968	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs544275156	chr10:27633995-27633996	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs149433306	chr10:27634039-27634040	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs541556185	chr10:27634076-27634077	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs183726296	chr10:27634106-27634107	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs16927745	chr10:27634154-27634155	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs547392071	chr10:27634194-27634195	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs370870884	chr10:27634197-27634198	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs111624769	chr10:27634198-27634199	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs373842356	chr10:27634219-27634220	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs79455097	chr10:27634228-27634229	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs79985270	chr10:27634242-27634243	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs552901234	chr10:27634354-27634355	Enhancers Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs144838353	chr10:27634400-27634401	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs79922304	chr10:27634509-27634510	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs371621054	chr10:27634522-27634523	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs555167015	chr10:27634523-27634524	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs568561981	chr10:27634556-27634557	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs533989243	chr10:27634583-27634584	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs554147805	chr10:27634591-27634592	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs562973754	chr10:27634623-27634624	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs41486847	chr10:27634667-27634668	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs545739808	chr10:27634675-27634676	Weak transcription Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs556018089	chr10:27634704-27634705	Weak transcription Flanking Active TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs77042007	chr10:27634719-27634720	Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs187559345	chr10:27634732-27634733	Weak transcription Flanking Active TSS Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs10829246	chr10:27634779-27634780	Weak transcription Flanking Active TSS Enhancers	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs527385724	chr10:27634801-27634802	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs77814050	chr10:27634815-27634816	Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs148567395	chr10:27634926-27634927	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs368604963	chr10:27634927-27634928	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
45	rs371846087	chr10:27634936-27634937	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs368910533	chr10:27635008-27635009	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs550893245	chr10:27635016-27635017	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs113106593	chr10:27635024-27635025	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs143977115	chr10:27635070-27635071	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs147290250	chr10:27635084-27635085	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:46)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	21525872	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:245 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:27633400-27634000	Enhancers	Brain Germinal Matrix	brain
2	chr10:27633400-27634400	Enhancers	ES-I3 Cell Line	embryonic stem cell
3	chr10:27633400-27634400	Enhancers	HUES48 Cell Line	embryonic stem cell
4	chr10:27633400-27634600	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr10:27633400-27634800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
6	chr10:27633600-27633800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
7	chr10:27633600-27634000	Enhancers	Cortex derived primary cultured neurospheres	brain
8	chr10:27633600-27634000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
9	chr10:27633600-27634000	Enhancers	GM12878-XiMat	blood
10	chr10:27633600-27634600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
11	chr10:27633600-27634800	Enhancers	Fetal Muscle Leg	muscle
12	chr10:27633800-27634400	Enhancers	Primary neutrophils fromperipheralblood	blood
13	chr10:27633800-27655400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr10:27634000-27634400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr10:27634000-27634400	Flanking Active TSS	Brain Germinal Matrix	brain
16	chr10:27634000-27634600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr10:27634000-27634600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
18	chr10:27634000-27634600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr10:27634000-27634800	Flanking Active TSS	GM12878-XiMat	blood
20	chr10:27634200-27634600	Enhancers	Primary B cells from peripheral blood	blood
21	chr10:27634200-27634600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
22	chr10:27634200-27634600	Enhancers	Right Atrium	heart
23	chr10:27634200-27634800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr10:27634200-27635400	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr10:27634200-27635400	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr10:27634400-27634600	Enhancers	Adipose Nuclei	Adipose
27	chr10:27634400-27634800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
28	chr10:27634400-27634800	Enhancers	Brain Germinal Matrix	brain
29	chr10:27634400-27635400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr10:27634400-27636400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
31	chr10:27634400-27636600	Weak transcription	HUES48 Cell Line	embryonic stem cell
32	chr10:27634600-27634800	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr10:27634600-27634800	Enhancers	Dnd41	blood
34	chr10:27634600-27635200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr10:27634600-27639600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
36	chr10:27634600-27643200	Weak transcription	Right Atrium	heart
37	chr10:27634800-27636000	Enhancers	GM12878-XiMat	blood
38	chr10:27634800-27637200	Enhancers	Primary neutrophils fromperipheralblood	blood
39	chr10:27634800-27638000	Weak transcription	Fetal Muscle Leg	muscle
40	chr10:27634800-27638800	Weak transcription	Brain Germinal Matrix	brain
41	chr10:27635000-27635800	Weak transcription	Dnd41	blood
42	chr10:27635200-27635400	Enhancers	Breast Myoepithelial Primary Cells	Breast
43	chr10:27635200-27636400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr10:27635400-27636400	Weak transcription	Primary monocytes fromperipheralblood	blood
45	chr10:27635400-27636400	Weak transcription	Monocytes-CD14+_RO01746	blood
46	chr10:27635400-27641600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
47	chr10:27635800-27637000	Enhancers	Dnd41	blood
48	chr10:27636400-27636600	Enhancers	Monocytes-CD14+_RO01746	blood
49	chr10:27636400-27636800	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr10:27636400-27637000	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links